Novartis AG (ADR) (NYSE:NVS)
CAPS Rating:
Operates in the business of patent-protected and generic pharmaceuticals as well as consumer health products.
The Official Website of the Long-Term Investor
Operates in the business of patent-protected and generic pharmaceuticals as well as consumer health products.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
NVS, Novartis, 119, 418 employees, based in Basel, Switzerland. Debt/equity of 0.36, market cap of 126.26 billion, relatively low price/earnings ratio as compared to others in industry, of 12.95. Diversified interests include vaccines, infectious disease treatment, and specifically, over-the-counter (OTC) drugs, animal health, and vision products.